Research ArticleANTI-DRUG ANTIBODIES

Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools

See allHide authors and affiliations

Science Translational Medicine  11 Jan 2017:
Vol. 9, Issue 372, eaag1286
DOI: 10.1126/scitranslmed.aag1286

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to
   Science Translational Medicine